Alder BioPharmaceuticals
Latest round
- Series D
Last raised
- Apr 2012
Total raised
- $105M
Investors
- 7
About Alder BioPharmaceuticals
Alder BioPharmaceuticals, Inc.Founded in 2004 in Bothell, US, Alder BioPharmaceuticals develops and commercializes therapeutic solutions targeting chronic pain and migraines. The company has executed a total of 7 deals since inception.Alder BioPharmaceuticals specializes in the development of monoclonal antibody therapies, focusing on migraine prevention and pain management. Their lead product candidates are designed to target the mechanisms of migraine and aim to improve the quality of life for patients suffering from chronic headaches. The company is focusing on launching its new therapies within the next few years, specifically targeting the migraine market in North America and Europe. The recent IPO has positioned Alder BioPharmaceuticals to enhance its R&D capabilities and potentially expand into other international markets as part of its long-term growth strategy.
Who invested in Alder BioPharmaceuticals
7 investors across 5 rounds
See all investors in Alder BioPharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alder BioPharmaceuticals
Who invested in Alder BioPharmaceuticals?
Alder BioPharmaceuticals has 7 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alder BioPharmaceuticals raised?
Alder BioPharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Alder BioPharmaceuticals last raise money?
Alder BioPharmaceuticals's most recent round on record is a Series D, in Apr 2012.
What does Alder BioPharmaceuticals do?
Alder BioPharmaceuticals is a pharmaceuticals company.
Where is Alder BioPharmaceuticals headquartered?
Alder BioPharmaceuticals is headquartered in Bothell, US.
Which VCs invest in companies like Alder BioPharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Alder BioPharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Alder BioPharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.